Siponimod is a drug that suppresses the function of the immune system. It is a so-called selective sphingosine-1-phosphate receptor modulator.
Siponimod is prescribed to treat multiple sclerosis (MS), in particular for the treatment of adults with secondary progressive multiple sclerosis (both relapsing and non-relapsing).
Siponimod and the benefit of DNA analysis
The rate at which siponimod is processed within your body varies from one individual to another. This means that the efficacy and side effects of siponimod can be predicted to some extent on the basis of your genes. Preventive DNA analysis can therefore be an important tool in optimising your medication.
Also known as
Mayzent